300272 开能健康
2024/06 - 中期
人民幣(K¥)
与去年同期
比较
2023/12
人民幣(K¥)
2022/12
人民幣(K¥)
2021/12
人民幣(K¥)
2020/12
人民幣(K¥)
营业总收入829,3294.23%1,671,6991,660,6421,511,4871,181,122
减:营业总成本725,8270.39%1,518,2421,533,8561,391,7461,062,573
    其中:营业成本493,4320.40%1,044,2881,096,8171,006,099665,346
               财务费用(2,310)-283.68%8,13911,07821,06029,747
               资产减值损失(1,961)1,478.49%(5,295)(23,594)(3,558)(82,210)
公允价值变动收益0--27,1227,362(2,430)(746)
投资收益(13,659)297.76%(22,461)(4,763)30,969(84)
    其中:对联营企业和合营企业的投资收益(13,659)297.75%(20,398)(6,638)(10,173)(952)
营业利润93,87929.96%161,807113,004152,18646,600
利润总额93,32429.86%158,805114,273145,49366,304
减:所得税费用20,12882.31%5,32815,23928,39115,776
净利润73,19620.34%153,47899,034117,10350,529
减:非控股权益16,164129.48%21,0316,47212,24324,111
股东净利润57,0326.04%132,44792,562104,86026,418

市场价值指针
每股收益 (元) *0.1000.00%0.2400.1600.1800.050
每股派息 (元) *0.050--0.1550.1000.1000.050
每股净资产 (元) *2.0236.62%2.1101.8892.0832.033
审计意见 #--标准的无保留意见标准的无保留意见标准的无保留意见标准的无保留意见
回页顶
备注: *未调整数据
#只提供简体内容